Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide)
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-24
DOI
10.1038/s41598-018-25169-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and Construction of Combinatory Cancer Hallmark–Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer
- (2016) Shanwu Gao et al. JAMA Oncology
- Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data
- (2015) Edwin Wang et al. SEMINARS IN CANCER BIOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival
- (2011) Niklas Thon et al. CANCER
- The ABCG2 resistance network of glioblastoma
- (2011) Anne-Marie Bleau et al. CELL CYCLE
- American Society of Clinical Oncology 2011 CNS tumors update
- (2011) Manmeet S Ahluwalia Expert Review of Anticancer Therapy
- Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
- (2011) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
- (2011) S. Spiegl-Kreinecker et al. NEURO-ONCOLOGY
- Recent Advances in Therapy for Glioblastoma
- (2010) Jennifer Clarke et al. ARCHIVES OF NEUROLOGY
- Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide
- (2010) N. Thon et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
- (2010) Michael Jansen et al. LANCET NEUROLOGY
- Frequent MGMT (06-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
- (2010) Martina Baur et al. Radiology and Oncology
- Identification of high-quality cancer prognostic markers and metastasis network modules
- (2010) Jie Li et al. Nature Communications
- Chemoradiotherapy of Newly Diagnosed Glioblastoma With Intensified Temozolomide
- (2009) Markus Weiler et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- Signaling network analysis of ubiquitin-mediated proteins suggests correlations between the 26S proteasome and tumor progression
- (2009) Cong Fu et al. Molecular BioSystems
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
- (2008) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now